Background： Nanotechnology is emerging as a promising tool to may pose a potential risk of toxicity during in vivo applications nanoparticles （RENPs） using mice as models. perform noninvasive therapy and optical im...Background： Nanotechnology is emerging as a promising tool to may pose a potential risk of toxicity during in vivo applications nanoparticles （RENPs） using mice as models. perform noninvasive therapy and optical imaging. Howevei; nanomedicinc In this study, we aimed to investigate the potential toxicity of rare-earth Methods： We synthesized RENPs through a typical co-precipitation method. Institute of Cancer Research （ICR） mice were randomly divided into seven groups including a control group and six experimental groups （10 mice per group）. [CR mice were intravenously injected with bare RENPs at a daily dose of 0, 0.5, 1.0, and 1.5 mg/kg for 7 days. To evaluate the toxicity of these nanoparticles in mice, magnetic resonance imaging （MRI） was performed to assess their uptake in mice. In addition, hematological and biochemical analyses were conducted to evaluate any impairment in the organ functions of ICR mice. The analysis of variance （ANOVA） followed by a one-way ANOVA test was used in this study. A repeated measures＇ analysis was used to determine any significant differences in white blood cell （WBC）, alanine aminotransferase （ALT）, and creatinine （CREA） levels at different evaluation times in each group. Results： We demonstrated the successful synthesis of two different sizes （10 nm and 100 nm） of RENPs. Their physical properties were characterized by transmission electron microscopy and a 980 nm laser diode. Results of MRI study revealed the distribution and circulation of the RENPs in the liver. In addition, the hematological analysis found an increase of WBCs to （8.69 ± 0.85） × 10^9/L at the 28^th day, which is indicative of inflammation in the mouse treated with 1.5 mg/kg NaYbF4：Er nanoparticles. Furthermore, the biochemical analysis indicated increased levels of ALT （[64.20 ± 15.50] U/L） and CREA （[27.80 ± 3.56] μmol/L） at the 28^th day, particularly those injected with 1.5 mg/kg NaYbF4：Er nanoparticles. These results suggested the physiological and pathological dalnage caused by these nanoparticles to the organs and tissues of mice, especially to liver and kidney. Conclusion： The use of bare RENPs may cause possible hepatotoxicity and nephritictoxicity in mice.展开更多
文摘Background： Nanotechnology is emerging as a promising tool to may pose a potential risk of toxicity during in vivo applications nanoparticles （RENPs） using mice as models. perform noninvasive therapy and optical imaging. Howevei; nanomedicinc In this study, we aimed to investigate the potential toxicity of rare-earth Methods： We synthesized RENPs through a typical co-precipitation method. Institute of Cancer Research （ICR） mice were randomly divided into seven groups including a control group and six experimental groups （10 mice per group）. [CR mice were intravenously injected with bare RENPs at a daily dose of 0, 0.5, 1.0, and 1.5 mg/kg for 7 days. To evaluate the toxicity of these nanoparticles in mice, magnetic resonance imaging （MRI） was performed to assess their uptake in mice. In addition, hematological and biochemical analyses were conducted to evaluate any impairment in the organ functions of ICR mice. The analysis of variance （ANOVA） followed by a one-way ANOVA test was used in this study. A repeated measures＇ analysis was used to determine any significant differences in white blood cell （WBC）, alanine aminotransferase （ALT）, and creatinine （CREA） levels at different evaluation times in each group. Results： We demonstrated the successful synthesis of two different sizes （10 nm and 100 nm） of RENPs. Their physical properties were characterized by transmission electron microscopy and a 980 nm laser diode. Results of MRI study revealed the distribution and circulation of the RENPs in the liver. In addition, the hematological analysis found an increase of WBCs to （8.69 ± 0.85） × 10^9/L at the 28^th day, which is indicative of inflammation in the mouse treated with 1.5 mg/kg NaYbF4：Er nanoparticles. Furthermore, the biochemical analysis indicated increased levels of ALT （[64.20 ± 15.50] U/L） and CREA （[27.80 ± 3.56] μmol/L） at the 28^th day, particularly those injected with 1.5 mg/kg NaYbF4：Er nanoparticles. These results suggested the physiological and pathological dalnage caused by these nanoparticles to the organs and tissues of mice, especially to liver and kidney. Conclusion： The use of bare RENPs may cause possible hepatotoxicity and nephritictoxicity in mice.
